Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Spine-Tech and Sulzer Orthopedics Biologics announce alliance

Oct. 6, 1997

Mitsui Toatsu's hGH enters clinical testing this month

Oct. 6, 1997

Efficacy of cholesterol biosynthesis inhibitor demonstrated in dogs

Oct. 6, 1997

Safety and efficacy data for INVICORP reported at impotence meeting

Oct. 6, 1997

SS-Cream evaluated in subjects with premature ejaculation

Oct. 6, 1997

Regeneron and P&G joint development program for obesity

Oct. 3, 1997

L-Arginine not associated with objective improvement in organic ED

Oct. 3, 1997

Linsidomine + moxisylyte for ED

Oct. 3, 1997

Effects of BQ-123 and BQ-788 on ET-1-induced corpus cavernosum contractions

Oct. 3, 1997

Intracavernous moxisylyte recommended for first-line treatment of ED

Oct. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...